NOVARTIS CEO - IF IMPACT ON US BUSINESS TOO HIGH REGARDING MFN, WILL CONSIDER LAUNCHING DRUGS IN PRIVATE MARKETS IN EUROPE

Reuters · 2d ago

Please log in to view news